LYON, France, Dec. 11, 2019 /PRNewswire/ — Mérieux Equity Partners is pleased to announce that the Mérieux Participations 3 fund (MP3) has entered the capital of Addmedica – a French pharmaceutical laboratory specialized in the development and marketing of high added value medical…
Merieux Equity Partners Announces It Has Entered the Capital of Addmedica – as a Reference Shareholder – in Order to Accelerate the Company’s Growth in France and Internationally
Read Full Article At The Original Source